420 related articles for article (PubMed ID: 12704641)
1. How families communicate about HNPCC genetic testing: findings from a qualitative study.
Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
[TBL] [Abstract][Full Text] [Related]
2. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
[TBL] [Abstract][Full Text] [Related]
3. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
[TBL] [Abstract][Full Text] [Related]
4. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
5. Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study.
McCann S; MacAuley D; Barnett Y; Bunting B; Bradley A; Jeffers L; Morrison PJ
Psychooncology; 2009 Nov; 18(11):1208-15. PubMed ID: 19177338
[TBL] [Abstract][Full Text] [Related]
6. Motivations and psychosocial impact of genetic testing for HNPCC.
Esplen MJ; Madlensky L; Butler K; McKinnon W; Bapat B; Wong J; Aronson M; Gallinger S
Am J Med Genet; 2001 Sep; 103(1):9-15. PubMed ID: 11562928
[TBL] [Abstract][Full Text] [Related]
7. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
[TBL] [Abstract][Full Text] [Related]
8. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management.
Lynch HT; Riley BD; Weissman SM; Coronel SM; Kinarsky Y; Lynch JF; Shaw TG; Rubinstein WS
Cancer; 2004 Jan; 100(1):53-64. PubMed ID: 14692024
[TBL] [Abstract][Full Text] [Related]
9. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
[TBL] [Abstract][Full Text] [Related]
10. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer.
Hadley DW; Jenkins JF; Dimond E; de Carvalho M; Kirsch I; Palmer CG
J Clin Oncol; 2004 Jan; 22(1):39-44. PubMed ID: 14701766
[TBL] [Abstract][Full Text] [Related]
11. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
[TBL] [Abstract][Full Text] [Related]
12. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
[TBL] [Abstract][Full Text] [Related]
13. Intention to learn results of genetic testing for hereditary colon cancer.
Vernon SW; Gritz ER; Peterson SK; Perz CA; Marani S; Amos CI; Baile WF
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):353-60. PubMed ID: 10207640
[TBL] [Abstract][Full Text] [Related]
14. Genetic counseling in hereditary nonpolyposis colorectal cancer: an extended family with MSH2 mutation.
Lynch HT; Lemon S; Smyrk T; Franklin B; Karr B; Lynch J; Slominski-Caster S; Murphy P; Connolly C
Am J Gastroenterol; 1996 Dec; 91(12):2489-93. PubMed ID: 8946971
[TBL] [Abstract][Full Text] [Related]
15. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members.
Keller M; Jost R; Haunstetter CM; Sattel H; Schroeter C; Bertsch U; Cremer F; Kienle P; Tariverdian M; Kloor M; Gebert J; Brechtel A
Clin Genet; 2008 Nov; 74(5):414-24. PubMed ID: 18954412
[TBL] [Abstract][Full Text] [Related]
17. Attitudes toward colon cancer gene testing: factors predicting test uptake.
Codori AM; Petersen GM; Miglioretti DL; Larkin EK; Bushey MT; Young C; Brensinger JD; Johnson K; Bacon JA; Booker SV
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):345-51. PubMed ID: 10207639
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.
Wakefield CE; Meiser B; Homewood J; Ward R; O'Donnell S; Kirk J;
Cancer; 2008 Sep; 113(5):956-65. PubMed ID: 18618513
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
Clin Genet; 2008 Sep; 74(3):233-42. PubMed ID: 18554281
[TBL] [Abstract][Full Text] [Related]
20. [Families at risk of colon cancer II. Hereditary nonpolyposis colorectal carcinoma].
Hlavatý T; Lukác L; Duris I
Vnitr Lek; 2004 Aug; 50(8):606-14. PubMed ID: 15521204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
